SEC Form 4 · accession 0001127602-19-009102

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chairman, President and CEO · Director

Period of report

Feb 27, 2019

Accepted (ET)

Mar 1, 2019 · 11:17 am EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001100682

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Feb 27, 2019	S	30	$140.695	D	293,331	D
Common Stock	Feb 27, 2019	S	200	$140.70	D	293,131	D
Common Stock	Feb 27, 2019	S	122	$140.705	D	293,009	D
Common Stock	Feb 27, 2019	S	462	$140.71	D	292,547	D
Common Stock	Feb 27, 2019	S	30	$140.715	D	292,517	D
Common Stock	Feb 27, 2019	S	200	$140.72	D	292,317	D
Common Stock	Feb 27, 2019	S	358	$140.73	D	291,959	D
Common Stock	Feb 27, 2019	S	300	$140.75	D	291,659	D
Common Stock	Feb 27, 2019	S	100	$140.76	D	291,559	D
Common Stock	Feb 27, 2019	S	202	$140.775	D	291,357	D
Common Stock	Feb 27, 2019	S	300	$140.79	D	291,057	D
Common Stock	Feb 27, 2019	S	100	$140.795	D	290,957	D
Common Stock	Feb 27, 2019	S	300	$140.80	D	290,657	D
Common Stock	Feb 27, 2019	S	100	$140.87	D	290,557	D
Common Stock	Feb 27, 2019	S	1	$140.88	D	290,556	D
Common Stock	Feb 27, 2019	S	269	$140.90	D	290,287	D
Common Stock	Feb 27, 2019	S	200	$140.91	D	290,087	D
Common Stock	Feb 27, 2019	S	100	$140.92	D	289,987	D
Common Stock	Feb 27, 2019	S	100	$140.96	D	289,887	D
Common Stock	Feb 27, 2019	S	100	$140.97	D	289,787	D
Common Stock	Feb 27, 2019	S	200	$140.98	D	289,587	D
Common Stock	Feb 27, 2019	S	100	$141.00	D	289,487	D
Common Stock	Feb 27, 2019	S	500	$141.10	D	288,987	D

No Table II lines on this filing.